Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesIs zoledronic acid an anticancer drug
Expert Opinion in Pharmacotherapy, 10/05/09
Doggrell SA – Zoledronic acid is used to prevent the bone loss associated with antioestrogen treatments in subjects with breast cancer. Zoledronic acid does have anticancer activity in premenopausal women with cancer.
Related Articles
Zoledronic Acid for the Prevention of Bone Loss in Postmenopausal Women With Low Bone Mass: A Randomized Controlled Trial
Obstetrics and Gynecology, 10/27/09
Relevance Score: 66%
Intravenous Zoledronic Acid to Prevent Osteoporosis in a Veteran Population With Multiple Risk Factors for Bone Loss on Androgen Deprivation Therapy
The Journal of Urology, 10/16/09
Relevance Score: 66%
Combination of Two Medications Help Postmenopausal Women with Osteoporosis
MedLinePlus, 10/30/09
Relevance Score: 64%
Orbital inflammatory disease secondary to a single-dose administration of zoledronic acid for treatment of postmenopausal osteoporosis
Osteoporosis International, 10/30/09
Relevance Score: 64%
Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial
Osteoporosis International, 10/06/09
Relevance Score: 64%
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Angiogenesis-inhibitors for metastatic thyroid cancer
Cochrane Reviews, 03/18/10
Metronomic chemotherapy in advanced soft tissue sarcomas
Cancer Chemotherapy and Pharmacology, 03/18/10
Non-Hodgkins Lymphoma in the Elderly
Drugs & Aging, 03/18/10
Article Search
Sponsor
Sponsor